MENU
CLYM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Climb Bio (CLYM) Earnings Date & Reports

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases... Show more

A.I. Advisor
published Earnings

CLYM is expected to report earnings to rise 17.92% to -15 cents per share on November 18

Climb Bio CLYM Stock Earnings Reports
Q3'25
Est.
$-0.15
Q2'25
Beat
by $0.05
Q1'25
Missed
by $0.16
The last earnings report on August 12 showed earnings per share of -12 cents, beating the estimate of -18 cents. With 803.87K shares outstanding, the current market capitalization sits at 161.28M.
View a ticker or compare two or three
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CLYM showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details